Summary & Overview
HCPCS G9783: Diabetes Patients with LDL-C <70 mg/dL Not on Statin Therapy
HCPCS Level II code G9783 documents clinical evidence that a patient with diabetes has a most recent fasting or direct LDL-C value below 70 mg/dL while not receiving statin therapy. This measure is relevant nationally for quality reporting and care management because LDL-C targets and statin use are central to cardiovascular risk reduction in people with diabetes. It signals cases where LDL-C is low without statin treatment, which may reflect prior therapy changes, intolerance, alternative lipid-lowering strategies, or documentation circumstances.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context, the settings in which it is typically reported, and which major payers include it in coverage or reporting workflows. The publication summarizes benchmarking and reporting implications, clarifies the clinical scenario captured by the code, and outlines where to look for related billing and quality-measure guidance. Data not available in the input is noted where applicable; the focus remains on national clinical and administrative relevance rather than jurisdictional policy detail.
Billing Code Overview
HCPCS Level II code G9783 documents patients with diabetes whose most recent fasting or direct LDL-C laboratory result is less than 70 mg/dL and who are not taking statin therapy. The measure captures clinical documentation of LDL-C control in a diabetic population in the context of lipid management.
Service Type: Laboratory result documentation and clinical evaluation related to lipid management
Typical Site of Service: Outpatient clinic or ambulatory care setting where diabetes management and laboratory review occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with type 2 diabetes mellitus presents for a routine chronic care visit at an outpatient primary care clinic. The clinician reviews recent laboratory results and documents a fasting LDL-C (direct LDL-C) of 62 mg/dL obtained within the health system laboratory three weeks earlier. The patient is not currently prescribed any statin therapy and has no recorded statin intolerance in the chart. The clinician documents the LDL-C value, confirms diabetes diagnosis in the problem list, and records the reason for not prescribing a statin (patient preference after shared decision-making) in the medical record. The workflow includes verification of diabetes diagnosis, retrieval of the most recent fasting or direct LDL-C result, assessment of current lipid-lowering medication list, counseling documentation, and placement of an order or plan if indicated. The typical site of service is an outpatient clinic or ambulatory primary care setting where laboratory results are available and medication management decisions are documented.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation supports significantly greater effort or complexity in counseling or documentation related to statin-nonuse and LDL-C assessment. |
23 |